Ask Our Doctors and Nurses!

OXALIPLATIN Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

OXALIPLATIN Safety Reports

Total OXALIPLATIN reports: 178.
OXALIPLATIN FDA safety alerts: No.
Reported deaths: 50    Reported hospitalizations: 127.
Take OXALIPLATIN Side Effects Survey or Share Your OXALIPLATIN Story. Read More Here.

Showing 1-75 of 178 Next >

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 15, 2006. Male patient, 55 years of age, weighting 121.0 lb, was diagnosed with neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: apnoea, asthenia, confusional state, fatigue, febrile neutropenia, heart rate increased, pneumonia, stridor. OXALIPLATIN dosage: 130MG/M2 Q 21 DAYS IV. During the same period patient was treated with TAXOTERE, BACITRACIN TOPICAL OINTMENT, DEXAMETHASONE, DELODIPINE SA, FOLIC ACID, LEVALBUTEROL, VITAMIN, ENSURE. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Aug 16, 2006. Female patient, 59 years of age, weighting 133.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, nausea, vomiting. OXALIPLATIN dosage: 140 MG DAYS 1+15 Q 28 DAY IV DRIP. During the same period patient was treated with XELODA, ZOFRAN, METHADON, DOXEPIM. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 16, 2006. Male patient, 54 years of age, weighting 175.9 lb, was diagnosed with rectal cancer metastatic and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: cough, infusion related reaction, nasal congestion, paraesthesia, urticaria. OXALIPLATIN dosage: 166MG IVPB OVER 2 HR. During the same period patient was treated with LEUCOVORIN CALCIUM. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Aug 16, 2006. Male patient, 79 years of age, weighting 165.3 lb, was diagnosed with malignant neoplasm of ampulla of vater and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: pyrexia. OXALIPLATIN dosage: 130MG/M2 IV Q3WKS. During the same period patient was treated with XELODA, DIAZEPAM, PHENYTOIN, LOVENOX, PROTONIX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 16, 2006. Male patient, 54 years of age, weighting 166.9 lb, was diagnosed with small intestine carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: disease progression, pyrexia. OXALIPLATIN dosage: 255MG IV Q3WEEKS. During the same period patient was treated with CAPECITABINE, CREAM, SEROQUEL, LAMICTAL. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Physician from UNITED STATES on June 28, 2006. Male patient, 78 years of age, was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: cholecystitis, diarrhoea, gallbladder pain, lung infiltration. OXALIPLATIN dosage: 85 MG/M2 QW2 INTRAVENOUS NOS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ATENOLOL, SIMVASTATIN, OMEPRAZOLE, LOPERAMIDE HYDROCHLORIDE, FENTANYL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 23, 2006. Male patient, weighting 151.0 lb, was diagnosed with neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, fall, swelling face, syncope vasovagal. OXALIPLATIN dosage: 115 MG DAY 1 + 15 Q 28 DA IV DRIP. During the same period patient was treated with XELODA, PERCOCET, SENOKOT, ASPIRIN, MEGACE, PROCRIT, KYTRIL, DECADRON. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, weighting 101.0 lb, was diagnosed with carcinoid tumour and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, white blood cell count decreased. OXALIPLATIN dosage: 120 MG Q2WEEKS IV. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, LOMOTIL, DECADRON, LORAZEPAM, GRANISETRON, OCTREOTIDE ACETATE. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 22, 2006. Male patient, 72 years of age, weighting 149.9 lb, was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, nausea, renal failure, vomiting. OXALIPLATIN dosage: 130 MG DAY 1, 8 Q 21 DAYS IV. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Aug 22, 2006. Male patient, 51 years of age, weighting 264.6 lb, was diagnosed with oesophageal carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: dysphagia, nausea, pain, pyrexia, vomiting. OXALIPLATIN dosage: 125 MG Q 7 DAYS IV. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 03, 2006. Male patient, 51 years of age, was diagnosed with leukaemia and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: disease progression, hepatic failure. OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUDARABINE SOLUTION, RITUXIMAB SOLUTION, CYTARABINE SOLUTION. Patient was hospitalized. Patient died on 07/27/2006.

OXALIPLATIN problem was reported by a Pharmacist from UNITED STATES on Aug 23, 2006. Male patient, 61 years of age, was diagnosed with colon cancer metastatic and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, antibody test positive, chromaturia, coombs direct test, dizziness, dyspnoea exertional, jaundice. OXALIPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on June 12, 2006. Male patient, 56 years of age, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: pyrexia. OXALIPLATIN dosage: . MG, 85 MG/M2 EVERY 2 WEEKS - INTRAVENOUS NOS. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, DEXAMETHASONE, LORAZEPAM, GRANISETRON, ACETAMINOPHEN, LOPERAMIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on June 12, 2006. Male patient, 56 years of age, weighting 176.0 lb, was diagnosed with endocrine neoplasm, pancreatic neoplasm and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, enteritis, febrile neutropenia, haematocrit decreased, haemoglobin decreased, small intestinal obstruction. OXALIPLATIN dosage: 170 MG, 85 MG/M2 EVERY 2 WEEKS - INTRAVENOUS NOS. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, DEXAMETHASONE. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on May 22, 2006. Male patient, 75 years of age, weighting 185.0 lb, was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: hepatitis, pancreatitis. OXALIPLATIN dosage: 168 MG Q2W - INTRAVENOUS NOS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2006. Male patient, 54 years of age, weighting 156.5 lb, was diagnosed with colorectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: body temperature increased, device migration, intestinal perforation, rectal perforation, white blood cell count increased. OXALIPLATIN dosage: 320 MG Q2W - INTRAVENOUS NOS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on June 01, 2006. Female patient, 79 years of age, was diagnosed with colorectal cancer stage iii and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, cardio-respiratory arrest, infusion related reaction. OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUVOCORIN, WARFARIN. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Physician from UNITED STATES on July 11, 2006. Male patient, 47 years of age, was diagnosed with colorectal cancer metastatic, metastases to lung and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, dizziness, hypotension. OXALIPLATIN dosage: 85 MG/M2 Q2W - INTRAVENOUS NOS. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 07, 2006. Male patient, 67 years of age, weighting 250.0 lb, was diagnosed with pancreatic neoplasm and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, aspartate aminotransferase increased, bacteraemia, chills, dehydration, diarrhoea, fatigue, flatulence, hypotension. OXALIPLATIN dosage: 200 MG; QOW; INTRA. During the same period patient was treated with BEVACIZUMAB SOLUTION, FLUOROURACIL, LEUCOVORIN CALCIUM, DEXAMETHASONE, LORAZEPAM, GRANISETRON, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Aug 25, 2006. Male patient, weighting 140.2 lb, was diagnosed with lung neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: pericardial effusion. OXALIPLATIN dosage: 85 MG/M2 IV D1+15. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 29, 2006. Male patient was diagnosed with lung neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, oral intake reduced. OXALIPLATIN dosage: 85 MG/M2 IV D1+15. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from BRAZIL on Aug 29, 2006. Male patient was diagnosed with colorectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, renal failure acute, sepsis, septic shock. OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, AVASTIN. Patient died.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 30, 2006. Male patient, 51 years of age, weighting 264.6 lb, was diagnosed with oesophageal carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: dysphagia, enterobacter infection, klebsiella infection, nausea, oesophagitis, pain, pyrexia, sputum culture positive, vomiting. OXALIPLATIN dosage: 125 MG Q 7 DAYS IV. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Physician from UNITED STATES on Aug 21, 2006. Male patient, 51 years of age, weighting 264.6 lb, was diagnosed with oesophageal adenocarcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: dysphagia, nausea, oesophagitis, pain, pyrexia, sputum culture positive, vomiting. OXALIPLATIN dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Aug 17, 2006. Male patient, 58 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: retinal haemorrhage. OXALIPLATIN dosage: 25 MG/M2 IV, DAY 1-4 INTRAVENOUS NOS. During the same period patient was treated with RITUXAN, CYTARABINE SOLUTION, FLUDARABINE SOLUTION, LEVOFLOXACIN, SULFAMETHOXAZOLE, VORICONAZOLE, VALACYCLOVIR, HUMULIN. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on June 22, 2006. Female patient, 60 years of age, was diagnosed with chronic lymphocytic leukaemia refractory and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: disease progression. OXALIPLATIN dosage: unknown. During the same period patient was treated with RITUXAN, CYTARABINE, FLUDARABINE, SULFAMETHOXAZOLE, VALACYCLOVIR, LEVOFLOXACIN, PIOGLITAZONE, EXENATIDE. Patient was hospitalized. Patient died on 06/21/2006.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Sept 12, 2006. Female patient, 65 years of age, was diagnosed with colorectal cancer metastatic and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia, ventricular fibrillation. OXALIPLATIN dosage: unknown. During the same period patient was treated with ZOFRAN, COMPAZINE, PERCOCET, FLUOROURACIL. Patient died on 07/21/2006.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 07, 2006. Female patient, weighting 189.6 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: anorexia, blood calcium decreased, blood chloride decreased, blood potassium decreased, blood sodium decreased, disease progression, failure to thrive, oral intake reduced. OXALIPLATIN dosage: 190 MG (100 MG/M2) ON DAYS 1 AND 15. During the same period patient was treated with GEMCITABINE, AVASTIN. Patient was hospitalized. Patient died on 01/23/2006.

Consumer or non-health professional from UNITED STATES reported OXALIPLATIN problem on June 05, 2006. Female patient, 48 years of age, was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, back pain, cholecystitis, gallbladder disorder, neutrophil count decreased, operative haemorrhage, prothrombin time prolonged, white blood cell count decreased. OXALIPLATIN dosage: unknown. During the same period patient was treated with BENTYL, AVASTIN. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 07, 2006. Female patient, weighting 189.6 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: anorexia, blood calcium decreased, blood potassium decreased, blood sodium decreased, disease progression, failure to thrive, stomatitis. OXALIPLATIN dosage: 190 MG (100 MG/M2) ON DAYS 1 AND 15. During the same period patient was treated with GEMCITABINE, AVASTIN. Patient was hospitalized. Patient died on 01/23/2006.

Physician from UNITED STATES reported OXALIPLATIN problem on Sept 14, 2006. Female patient, weighting 62.83 lb, was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: convulsion, reversible posterior leukoencephalopathy syndrome. OXALIPLATIN dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Physician from UNITED STATES on Sept 19, 2006. Female patient was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: catheter related infection, enteritis, haemoptysis, mucosal inflammation, neurotoxicity, platelet count decreased, pneumothorax, pseudomonal sepsis, septic embolus. OXALIPLATIN dosage: 85 MG/M2 (165 MG). During the same period patient was treated with LEUCOVORIN CALCIUM, ERBITUX, AVASTIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Sept 11, 2006. Male patient, 56 years of age, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: enteritis, febrile neutropenia, small intestinal obstruction. OXALIPLATIN dosage: 170 MG;Q2W;IV. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, DEXAMETHASONE, LORAZEPAM, GRANISETRON, ACETAMINOFEN. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Male patient, 51 years of age, was diagnosed with leukaemia and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: disease progression, hepatic failure. OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUDARABINE, CYTARABINE. Patient was hospitalized. Patient died on 07/27/2006.

Health Professional from BRAZIL reported OXALIPLATIN problem on Aug 29, 2006. Male patient was diagnosed with colorectal cancer metastatic and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, sepsis. OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, AVASTIN. Patient died on 08/12/2006.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Oct 05, 2006. Male patient, 51 years of age, weighting 272.5 lb, was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: pyrexia. OXALIPLATIN dosage: 299 MG Q21 D IV. During the same period patient was treated with CAPECITABINE, NAPROSYN, HYDROCODONE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported OXALIPLATIN problem on Oct 12, 2006. Male patient, 74 years of age, weighting 201.1 lb, was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: rash. OXALIPLATIN dosage: 170MG, 170MG X 1 INTRAVEN. Patient recovered.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2006. Male patient, weighting 206.0 lb, was diagnosed with neuroendocrine carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, condition aggravated, fatigue. OXALIPLATIN dosage: 170 MG Q2WEEKS IV. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL, BEVACIZUMAB, SANDOSTATIN LAR, LASIX, ACYCLOVIR, SPIRONOLACTONE, ARANESP. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported OXALIPLATIN problem on Oct 16, 2006. Male patient, weighting 206.0 lb, was diagnosed with neuroendocrine carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: ascites, condition aggravated, fatigue, haemoglobin decreased, laboratory test interference, liver function test abnormal, performance status decreased. OXALIPLATIN dosage: 170 MG Q2WEEKS IV. During the same period patient was treated with LEUCOVORIN, BEVACIZUMAB, SANDOSTATIN LAR, LASIX, ACYCLOVIR, SPIRONOLACTONE, ARANESP. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 06, 2006. Male patient, 65 years of age, was diagnosed with metastatic gastric cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: convulsion. OXALIPLATIN dosage: unknown. During the same period patient was treated with ATENOLOL, XANAX, PREVACID, DOXAZOSIN, BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported OXALIPLATIN problem on Oct 12, 2006. Male patient was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, fatigue, hypophosphataemia, hypotension, infection, neutrophil count decreased. OXALIPLATIN dosage: 85 MG/M2 (156 MG). During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED KINGDOM on Oct 13, 2006. Male patient, 63 years of age, weighting 198.4 lb, was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, diarrhoea, fall, fatigue. OXALIPLATIN dosage: unknown. During the same period patient was treated with XELODA. Patient was hospitalized. Patient died on 08/04/2006.

Physician from UNITED STATES reported OXALIPLATIN problem on Sept 19, 2006. Female patient was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: catheter related infection, enteritis, haemoptysis, mucosal inflammation, neurotoxicity, platelet count decreased, pneumothorax, pseudomonal sepsis, transient ischaemic attack. OXALIPLATIN dosage: 85 MG/M2 (165 MG). During the same period patient was treated with LEUCOVORIN CALCIUM, CETUXIMAB, BEVACIZUMAB, FLUOROURACIL. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 07, 2006. Female patient, weighting 189.6 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: anorexia, disease progression, failure to thrive, laboratory test abnormal, stomatitis. OXALIPLATIN dosage: 190 MG (100 MG/M2) ON DAYS 1 AND 15. During the same period patient was treated with GEMCITABINE, BEVACIZUMAB. Patient was hospitalized. Patient died on 01/23/2006.

Physician from UNITED STATES reported OXALIPLATIN problem on Oct 23, 2006. Female patient, weighting 121.3 lb, was diagnosed with colorectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, asthenia, candidiasis, dehydration, diarrhoea, fatigue, oral intake reduced. OXALIPLATIN dosage: unknown. During the same period patient was treated with KYTRIL, IMODIUM, DEXAMETHASONE, ARANESP, ALOXI, IRINOTECAN, BEVACIZUMAB. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 27, 2006. Male patient, weighting 206.0 lb, was diagnosed with neuroendocrine carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: ascites, failure to thrive, haemoglobin abnormal, liver function test abnormal, malignant neoplasm progression, neuroendocrine tumour, performance status decreased. OXALIPLATIN dosage: 170 MG Q2WEEKS IV. During the same period patient was treated with LEUCOVORIN, BEVACIZUMAB, SANDOSTATIN LAR, LASIX, ACYCLOVIR, SPIRONOLACTONE, ARANESP. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported OXALIPLATIN problem on Oct 26, 2006. Male patient, weighting 205.9 lb, was diagnosed with neuroendocrine tumour and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: ascites, disease progression, failure to thrive, liver function test abnormal. OXALIPLATIN dosage: 170 MG (85 MG/M2) EVERY TWO WEEKS. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN, LOMOTIL, IMODIUM, ARANESP, SPIRONOLACTONE, ACYCLOVIR. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Nov 02, 2006. Male patient, 72 years of age, weighting 149.9 lb, was diagnosed with oesophageal carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, aspiration, chronic obstructive pulmonary disease, constipation, dehydration, diarrhoea, haemodialysis, hypotension, hypoxia. OXALIPLATIN dosage: 130 MG DAY 1, 8 Q 21 DAYS IV. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 10/24/2006.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Nov 03, 2006. Male patient, weighting 140.2 lb, was diagnosed with lung neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: pericardial effusion, pericardial effusion malignant, pleural effusion, pyrexia. OXALIPLATIN dosage: 85 MG/M2 IV D1 + 15. During the same period patient was treated with DOCETAXOL. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from JAPAN on Oct 27, 2006. Female patient, 50 years of age, was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: hepatic failure. OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE. Patient died on 10/06/2006.

Physician from UNITED STATES reported OXALIPLATIN problem on Aug 21, 2006. Male patient, 72 years of age, weighting 149.9 lb, was diagnosed with oesophageal adenocarcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: constipation, dehydration, diarrhoea, hypotension, hypoxia, mental status changes, metabolic acidosis, mucosal inflammation, nausea. OXALIPLATIN dosage: 130 MG ON DAYS 1 AND 8 EVERY 21 DAYS. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 10/24/2006.

OXALIPLATIN problem was reported by a Physician from UNITED STATES on Nov 07, 2006. Female patient, 77 years of age, weighting 88.00 lb, was diagnosed with rectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, frequent bowel movements, hypotension, nausea, pelvic pain, respiratory distress, vomiting. OXALIPLATIN dosage: 60 MG/M2 WEEKLY IV DRIP. During the same period patient was treated with SYNTHROID, ALBUTEROL, REGLAN, FLUOROURACIL, DOLASETRON, LORAZEPAM, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported OXALIPLATIN problem on Nov 10, 2006. Male patient, 56 years of age, weighting 210.1 lb, was diagnosed with neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, flushing, infusion related reaction, paraesthesia oral, rash, urticaria. OXALIPLATIN dosage: 180 MG Q 2 WEEKS IV DRIP. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Physician from UNITED STATES on Oct 23, 2006. Female patient, weighting 121.3 lb, was diagnosed with colorectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, dehydration, empyema, fatigue, pleural effusion, pleural infection, pneumonitis, respiratory failure. OXALIPLATIN dosage: unknown. During the same period patient was treated with KYTRIL, IMODIUM, DEXAMETHASONE, ARANESP, ALOXI, IRINOTECAN, BEVACIZUMAB. Patient was hospitalized. Patient died on 11/02/2006.

Health Professional from SPAIN reported OXALIPLATIN problem on Nov 10, 2006. Male patient, weighting 173.5 lb, was diagnosed with neurological symptom and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: disease progression, thrombocytopenic purpura. OXALIPLATIN dosage: unknown. During the same period patient was treated with METOCLOPRAMID, LORAZEPAM, METAMIZOLE MAGNESIUM, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient died on 11/12/2006.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Nov 16, 2006. Male patient, weighting 184.0 lb, was diagnosed with colon cancer metastatic and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, dehydration, diarrhoea, dyspnoea, nausea, small intestinal obstruction, vomiting. OXALIPLATIN dosage: 256.1 MG. Q3W, IV. During the same period patient was treated with BEVACIZUMAB, CLEOCIN T GEL, RESTORIL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported OXALIPLATIN problem on Oct 23, 2006. Female patient, weighting 121.3 lb, was diagnosed with colorectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, dehydration, empyema, fatigue, pleural effusion, pneumonitis, respiratory failure. OXALIPLATIN dosage: unknown. During the same period patient was treated with KYTRIL, IMODIUM, DEXAMETHASONE, ARANESP, ALOXI, IRINOTECAN, BEVACIZUMAB. Patient was hospitalized. Patient died on 11/02/2006.

OXALIPLATIN problem was reported by a Health Professional from SPAIN on Nov 10, 2006. Male patient, weighting 173.5 lb, was diagnosed with neurological symptom and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, splenic haematoma, thrombocytopenic purpura. OXALIPLATIN dosage: unknown. During the same period patient was treated with METOCLOPRAMID, LORAZEPAM, METAMIZOLE MAGNESIUM, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient died on 11/12/2006.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Nov 28, 2006. Male patient, 75 years of age, weighting 125.7 lb, was diagnosed with rectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: fall, fatigue. OXALIPLATIN dosage: 40 MG/M2 IV. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL. Patient died on 11/16/2006.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Nov 27, 2006. Male patient, 66 years of age, weighting 150.4 lb, was diagnosed with oesophageal carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: anorexia, atrial flutter, dehydration, diarrhoea, dysphagia, nausea, tachycardia, vomiting. OXALIPLATIN dosage: 125 MG Q 7 DAYS IV. During the same period patient was treated with CAPECITABINE, TOPROL, LISINOPRIL, SUCRALFATE, NEXIUM, LIPITOR, PLAVIX, COLACE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Nov 28, 2006. Male patient, 50 years of age, was diagnosed with oesophageal carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, sick sinus syndrome. OXALIPLATIN dosage: 80 MG (40 MG/M2/WEEK) SCHEDULED FOR 5 WEEKS. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Physician from UNITED STATES on Aug 21, 2006. Male patient, 72 years of age, weighting 149.9 lb, was diagnosed with oesophageal adenocarcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial tachycardia, constipation, dehydration, diarrhoea, hypotension, hypoxia, mental status changes, metabolic acidosis, mucosal inflammation. OXALIPLATIN dosage: 130 MG ON DAYS 1 AND 8 EVERY 21 DAYS. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 10/24/2006.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Dec 01, 2006. Male patient, 59 years of age, weighting 166.2 lb, was diagnosed with lung neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: pain management. OXALIPLATIN dosage: 85MG/M2 DAYS 1 + 15. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2006. Male patient, 56 years of age, weighting 280.0 lb, was diagnosed with colon cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: gait disturbance, nerve injury. OXALIPLATIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported OXALIPLATIN problem on Oct 26, 2006. Male patient, weighting 205.9 lb, was diagnosed with neuroendocrine tumour and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, brain natriuretic peptide increased, cyanosis, disease progression, failure to thrive, haemoglobin abnormal, metastases to liver, performance status decreased, pneumonia. OXALIPLATIN dosage: 170 MG (85 MG/M2) EVERY TWO WEEKS. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, LOMOTIL, IMODIUM, ARANESP, SPIRONOLACTONE, ACYCLOVIR, LASIX. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Physician from JAPAN on Dec 01, 2006. Female patient, 69 years of age, was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: angina pectoris. OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEVOFOLINTE CALCIUM. Patient recovered.

Physician from UNITED STATES reported OXALIPLATIN problem on Dec 12, 2006. Male patient, weighting 198.4 lb, was diagnosed with colon cancer stage iii and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: colon cancer, cryptococcosis, cytomegalovirus antibody positive, dyspnoea, fatigue, fungus sputum test positive, lung infiltration, metastases to lymph nodes, neuropathy. OXALIPLATIN dosage: 85MG/M2 EVERY 2WKS IV. Patient died on 09/05/2006.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Dec 15, 2006. Male patient, 71 years of age, weighting 206.8 lb, was diagnosed with oesophageal carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: cellulitis, erythema, injection site reaction, oedema peripheral, pain in extremity. OXALIPLATIN dosage: 70 MG/M2 Q 7 DAYS IV. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Dec 14, 2006. Male patient, weighting 170.6 lb, was diagnosed with lung neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: brain oedema, headache. OXALIPLATIN dosage: 85 MG/M2. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from JAPAN on Dec 13, 2006. Male patient, 75 years of age, was diagnosed with rectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. OXALIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on Dec 20, 2006. Male patient, 71 years of age, weighting 213.4 lb, was diagnosed with oesophageal carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: cellulitis. OXALIPLATIN dosage: 70 MG/M2 Q 7 DAYS IV. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Health Professional from UNITED STATES on Dec 28, 2006. Male patient, 59 years of age, weighting 170.6 lb, was diagnosed with lung neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: bacillus infection, blood culture positive, staphylococcal infection. OXALIPLATIN dosage: 85MG/M2 DAYS 1 + 15 /Q28 IV. During the same period patient was treated with DOCETAXEL DAYS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported OXALIPLATIN problem on July 10, 2007. Male patient, 60 years of age, weighting 173.0 lb, was diagnosed with oesophageal carcinoma and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood potassium decreased, dehydration, diarrhoea, hypovolaemia. OXALIPLATIN dosage: 78 MG D1 - D8 IV. During the same period patient was treated with XELODA, TAXOTERE. Patient was hospitalized. Patient recovered.

OXALIPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Male patient, weighting 120.2 lb, was diagnosed with neoplasm malignant and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, hypokalaemia, hyponatraemia, hypovolaemia. OXALIPLATIN dosage: 130MG/M2 Q 21 DAYS I.V.. During the same period patient was treated with CETUXIMAB, ACIPHEX, HYDROCHLOROTHIAZIDE, IRON SULPHATETHIAMIN COMPOUND, CELEBREX, TRIAMCINOLONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ITALY reported OXALIPLATIN problem on July 02, 2007. Female patient, 76 years of age, was diagnosed with rectal cancer and was treated with OXALIPLATIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, carcinoembryonic antigen increased, disease progression, metastases to lung, metastases to salivary gland, metastases to skin, mucosal inflammation, rectal cancer metastatic, treatment noncompliance. OXALIPLATIN dosage: 100 MG/M2, ON DAY 1, REPEATED EVERY 14 DAYS,. During the same period patient was treated with FLUOROURACIL, RALTITREXED. Patient died on 05/01/2006.

Showing 1-75 of 178 Next >